Takeda Pharmaceutical Co Ltd (TKPHF)
26.62
+0.56
(+2.15%)
USD |
OTCM |
May 01, 16:00
Takeda Pharmaceutical Price to Book Value: 0.8735 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 0.8735 |
| April 30, 2024 | 0.8551 |
| April 29, 2024 | 0.8551 |
| April 26, 2024 | 0.8551 |
| April 25, 2024 | 0.8218 |
| April 24, 2024 | 0.8457 |
| April 23, 2024 | 0.8457 |
| April 22, 2024 | 0.8457 |
| April 19, 2024 | 0.8457 |
| April 18, 2024 | 0.8703 |
| April 17, 2024 | 0.8703 |
| April 16, 2024 | 0.8703 |
| April 15, 2024 | 0.8703 |
| April 12, 2024 | 0.8703 |
| April 11, 2024 | 0.8703 |
| April 10, 2024 | 0.8703 |
| April 09, 2024 | 0.8877 |
| April 08, 2024 | 0.8726 |
| April 05, 2024 | 0.8943 |
| April 04, 2024 | 0.8671 |
| April 03, 2024 | 0.8762 |
| April 02, 2024 | 0.8762 |
| April 01, 2024 | 0.916 |
| March 28, 2024 | 0.9337 |
| March 27, 2024 | 0.9337 |
| Date | Value |
|---|---|
| March 26, 2024 | 0.9337 |
| March 25, 2024 | 0.9337 |
| March 22, 2024 | 0.9495 |
| March 21, 2024 | 0.9495 |
| March 20, 2024 | 0.9495 |
| March 19, 2024 | 0.9495 |
| March 18, 2024 | 0.9495 |
| March 15, 2024 | 0.9495 |
| March 14, 2024 | 0.9495 |
| March 13, 2024 | 0.9656 |
| March 12, 2024 | 0.9656 |
| March 11, 2024 | 0.9737 |
| March 08, 2024 | 0.9737 |
| March 07, 2024 | 0.9353 |
| March 06, 2024 | 0.9353 |
| March 05, 2024 | 0.9353 |
| March 04, 2024 | 0.9353 |
| March 01, 2024 | 0.9463 |
| February 29, 2024 | 0.9396 |
| February 28, 2024 | 0.9396 |
| February 27, 2024 | 0.9396 |
| February 26, 2024 | 0.9396 |
| February 23, 2024 | 0.9396 |
| February 22, 2024 | 0.9343 |
| February 21, 2024 | 0.9518 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8218
Minimum
Apr 25 2024
1.452
Maximum
Nov 19 2019
1.096
Average
1.075
Median
Jan 18 2023
Price to Book Value Benchmarks
| Nxera Pharma Co Ltd | 1.757 |
| PeptiDream Inc | 5.939 |
| Stemcell Holdings Inc | -- |
| Healios KK | 3.273 |
Price to Book Value Related Metrics
| PE Ratio | 33.15 |
| PS Ratio | 1.412 |
| Price | 26.62 |
| Earnings Yield | 3.02% |
| Market Cap | 41.76B |
| Operating PE Ratio | 16.91 |
| Normalized PE Ratio | 33.15 |